Continuous Pharmaceutical Manufacturing
This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Special Issue Information
Dear Colleagues,
Pharmaceutical manufacturing is facing the greatest ideological revolution since industrial drug manufacturing. Drugs have been traditionally manufactured in batch mode, but now the continuous manufacturing has started to gain a serious interest in the pharmaceutical industry. The pharma industry is heavily regulated by authorizing bodies (FDA, EMA, etc.), but already, over a decade, regulatory bodies have enabled and even encouraged the change from batch to continuous manufacturing by publishing several guidelines on how to implement continuous manufacturing. Advantages of continuous manufacturing are indisputable. The quality by design framework provides the cornerstone for better process understanding and ultimately higher product quality for patients. New modes of manufacturing of drugs require a substantial amount of research from the pharmaceutical industry, academia, and various research institutions. This Special Issue: “Continuous Pharmaceutical Manufacturing” is intended to cover the whole spectrum of all relevant aspects of continuous manufacturing. Starting from the fundamental science of detailed phenomenon in continuous manufacturing and ending in how applied science can put continuous manufacturing into practice.
Dr. Ossi Korhonen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- continuous manufacturing of pharmaceuticals
- Quality by Design
- risk assessment in continuous manufacturing
- Design of Experiment in continuous manufacturing
- Design Space
- Process Analytical Techniques (PAT) in continuous manufacturing
- real-time process monitoring
- data analysis of process data
- process simulations
- process control and automation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Published Papers
Pharmaceutics - ISSN 1999-4923